Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Study 1.2 (Stress Manipulation)

Active, not recruitingOBSERVATIONAL
Enrollment

148

Participants

Timeline

Start Date

January 19, 2021

Primary Completion Date

March 31, 2025

Study Completion Date

December 1, 2025

Conditions
Major Depression in Remission
Interventions
DEVICE

Aversive stimuli

Electrotactile stimulation will be used as the aversive stimulus. The aversive stimulus is delivered in the form of a mild half-second stimulation to the ankle, calibrated to a subjective threshold that is uncomfortable but not painful. This stimulation is delivered by Digitimer DS8R Constant Current Stimulator (Digitimer North America, LLC. Ft. Lauderdale, FL). Its previous model DS71 has been safely implemented in studies with previously MGH-approved IRB's (Milad et al., 2013).

Trial Locations (1)

02478

McLean Hospital, Belmont

All Listed Sponsors
lead

Mclean Hospital

OTHER